Polyfunctional t cells accumulate in large human cytomegalovirus-specific t cell responses

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 1001-1009

  Lachmann, Raskit ^a   Bajwa, Martha ^a   Vita, Serena ^b   Smith, Helen ^a   Cheek, Elizabeth ^d   Akbar, Arne ^c   Kern, Florian ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD40 LIGAND; CD45RA ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 84856822945     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00873-11     Document Type: Article

References (50)

1. Almeida JR, et al. 2009. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
2. Appay V, van Lier RA, Sallusto F, Roederer M. 2008. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73:975-983.
3. Betts MR, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
4. Bunde T, et al. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201:1031-1036.
5. Casazza JP, et al. 2006. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 203:2865-2877.
6. Chen SF, et al. 2004. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J. Infect. Dis. 189: 1619-1627.
7. Chidrawar S, et al. 2009. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 155:423-432.
8. Ciuffreda D, et al. 2008. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur. J. Immunol. 38:2665-2677.
9. Darrah PA, et al. 2007. Multifunctional TH1 cells define a correlate of vaccinemediated protection against Leishmania major. Nat. Med. 13:843-850.
10. Derhovanessian E, et al. 2010. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 185:4618-4624.
11. Duvall MG, et al. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38:350-363.
12. Elias D, Akuffo H, Britton S. 2005. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99:363-368.
13. Engstrand M, et al. 2003. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin. Exp. Immunol. 132:96-104.
14. Hadrup SR, et al. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176:2645-2653.
15. Hamann D, et al. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407-1418.
16. Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H. 2004. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 86:41-44.
17. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. 2007. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81:8468-8476.
18. Karrer U, et al. 2003. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 170:2022-2029.
19. Kern F, et al. 2002. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185:1709-1716.
20. Kern F, et al. 2000. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30:1676-1682.
21. Khan N, et al. 2007. T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection. J. Immunol. 178:4455-4465.
22. Khan N, et al. 2004. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173:7481-7489.
23. Kohrt HE, et al. 2005. Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses. J. Immunother. 28:297-305.
24. McElhaney JE, Effros RB. 2009. Immunosenescence: what does it mean to health outcomes in older adults? Curr. Opin. Immunol. 21:418-424.
25. Munks MW, Pinto AK, Doom CM, Hill AB. 2007. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell im-munodominance in murine cytomegalovirus infection. J. Immunol. 178: 7235-7241.
26. Ndhlovu ZM, Oelke M, Schneck JP, Griffin DE. 2010. Dynamic regulation of functionally distinct virus-specific T cells. Proc. Natl. Acad. Sci. U. S. A. 107:3669-3674.
27. Nebbia G, et al. 2008. Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am. J. Transplant. 8:2590-2599.
28. Nesbit L, Johnson SM, Pappagianis D, Ampel NM. 2010. Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells. Infect. Immun. 78:309-315.
29. Ouyang Q, et al. 2003. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38:911-920.
30. Ouyang Q, Wagner WM, Wikby A, Remarque E, Pawelec G. 2002. Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? Eur. Cytokine Netw. 13:392-394.
31. Ouyang Q, et al. 2003. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominantCMVepitope in the very old. J. Clin. Immunol. 23:247-257.
32. Ouyang Q, et al. 2004. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp. Gerontol. 39:607-613.
33. Pita-Lopez ML, et al. 2009. Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun. Ageing 6:11.
34. Pourgheysari B, et al. 2007. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J. Virol. 81:7759-7765.
35. Quigley MF, et al. 2010. Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. Proc. Natl. Acad. Sci. U. S. A. 107:19414-19419.
36. Rentenaar RJ, et al. 2000. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J. Clin. Invest. 105:541-548.
37. Schwanninger A, et al. 2008. Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun. Ageing 5:14.
38. Seder RA, Ahmed R. 2003. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4:835-842.
39. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8:247-258.
40. Sester M, et al. 2002. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 76:3748-3755.
41. Sester U, et al. 2005. Differences in CMV-specific T-cell levels and longterm susceptibility to CMV infection after kidney, heart and lung transplantation. Am. J. Transplant. 5:1483-1489.
42. Sester U, et al. 2008. PD-1 expression and IL-2 loss of cytomegalovirusspecific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 8:1486-1497.
43. Snyder CM, et al. 2009. CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J. Immunol. 183:3932-3941.
44. Sund F, et al. 2010. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study. Clin. Transplant. 24:401-409.
45. Sylwester AW, et al. 2005. Broadly targeted human cytomegalovirusspecific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
46. Turner JE, et al. 2010. Latent cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise. Brain Behav. Immun. 24:1362-1370.
47. Valitutti S, Muller S, Dessing M, Lanzavecchia A. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
48. Valitutti S, Muller S, Salio M, Lanzavecchia A. 1997. Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J. Exp. Med. 185:1859-1864.
49. Vescovini R, et al. 2007. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J. Immunol. 179:4283-4291.
50. Weyand CM, Goronzy J, Fathman CG. 1987. Modulation of CD4 by antigenic activation. J. Immunol. 138:1351-1354.